Prior systemic injection of MDP protects NOD2-intact mice from TNBS-induced colitis, whose effects are accompanied by diminished NF-κB activation and proinflammatory cytokine responses against multiple TLR ligands in the colonic lamina propria immune cells (28). The gene discussed is NFKB1; the disease is colitis.